1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-opioid Pain Patches Revenue
1.4 Market Analysis by Type
1.4.1 Global Non-opioid Pain Patches Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lidocaine Patch
1.4.3 Diclofenac Patch
1.4.4 Methyl Salicylate Patch
1.4.5 Capsaicin Patch
1.4.6 Ketoprofen Patch
1.4.7 Other
1.5 Market by Application
1.5.1 Global Non-opioid Pain Patches Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies & Drug Stores
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Non-opioid Pain Patches Market
1.8.1 Global Non-opioid Pain Patches Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patches Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Non-opioid Pain Patches Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Non-opioid Pain Patches Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Non-opioid Pain Patches Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Non-opioid Pain Patches Sales Volume Market Share by Region (2015-2020)
3.2 Global Non-opioid Pain Patches Sales Revenue Market Share by Region (2015-2020)
3.3 North America Non-opioid Pain Patches Sales Volume
3.3.1 North America Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.3.2 North America Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Non-opioid Pain Patches Sales Volume
3.4.1 East Asia Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Non-opioid Pain Patches Sales Volume (2015-2020)
3.5.1 Europe Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Non-opioid Pain Patches Sales Volume (2015-2020)
3.6.1 South Asia Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Non-opioid Pain Patches Sales Volume (2015-2020)
3.7.1 Southeast Asia Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Non-opioid Pain Patches Sales Volume (2015-2020)
3.8.1 Middle East Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Non-opioid Pain Patches Sales Volume (2015-2020)
3.9.1 Africa Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Non-opioid Pain Patches Sales Volume (2015-2020)
3.10.1 Oceania Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Non-opioid Pain Patches Sales Volume (2015-2020)
3.11.1 South America Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.11.2 South America Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Non-opioid Pain Patches Sales Volume (2015-2020)
3.12.1 Rest of the World Non-opioid Pain Patches Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Non-opioid Pain Patches Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Non-opioid Pain Patches Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Non-opioid Pain Patches Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Non-opioid Pain Patches Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Non-opioid Pain Patches Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Non-opioid Pain Patches Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Non-opioid Pain Patches Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Non-opioid Pain Patches Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Non-opioid Pain Patches Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Non-opioid Pain Patches Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Non-opioid Pain Patches Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Non-opioid Pain Patches Sales Volume Market Share by Type (2015-2020)
14.2 Global Non-opioid Pain Patches Sales Revenue Market Share by Type (2015-2020)
14.3 Global Non-opioid Pain Patches Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Non-opioid Pain Patches Consumption Volume by Application (2015-2020)
15.2 Global Non-opioid Pain Patches Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Non-opioid Pain Patches Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Non-opioid Pain Patches Product Specification
16.1.3 Pfizer Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 TEH SENG Pharmaceutical
16.2.1 TEH SENG Pharmaceutical Company Profile
16.2.2 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Specification
16.2.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Novartis AG
16.3.1 Novartis AG Company Profile
16.3.2 Novartis AG Non-opioid Pain Patches Product Specification
16.3.3 Novartis AG Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 GlaxoSmithKline
16.4.1 GlaxoSmithKline Company Profile
16.4.2 GlaxoSmithKline Non-opioid Pain Patches Product Specification
16.4.3 GlaxoSmithKline Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Hisamitsu Pharmaceutical
16.5.1 Hisamitsu Pharmaceutical Company Profile
16.5.2 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Specification
16.5.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Johnson & Johnson
16.6.1 Johnson & Johnson Company Profile
16.6.2 Johnson & Johnson Non-opioid Pain Patches Product Specification
16.6.3 Johnson & Johnson Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 IBSA Institut Biochimque SA
16.7.1 IBSA Institut Biochimque SA Company Profile
16.7.2 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Specification
16.7.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Teva Pharmaceutical Industries
16.8.1 Teva Pharmaceutical Industries Company Profile
16.8.2 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Specification
16.8.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Mylan N.V.
16.9.1 Mylan N.V. Company Profile
16.9.2 Mylan N.V. Non-opioid Pain Patches Product Specification
16.9.3 Mylan N.V. Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Teikoku Seiyaku
16.10.1 Teikoku Seiyaku Company Profile
16.10.2 Teikoku Seiyaku Non-opioid Pain Patches Product Specification
16.10.3 Teikoku Seiyaku Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Acorda Therapeutics
16.11.1 Acorda Therapeutics Company Profile
16.11.2 Acorda Therapeutics Non-opioid Pain Patches Product Specification
16.11.3 Acorda Therapeutics Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Allergan PLC
16.12.1 Allergan PLC Company Profile
16.12.2 Allergan PLC Non-opioid Pain Patches Product Specification
16.12.3 Allergan PLC Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Endo International
16.13.1 Endo International Company Profile
16.13.2 Endo International Non-opioid Pain Patches Product Specification
16.13.3 Endo International Non-opioid Pain Patches Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Non-opioid Pain Patches Manufacturing Cost Analysis
17.1 Non-opioid Pain Patches Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Non-opioid Pain Patches
17.4 Non-opioid Pain Patches Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Non-opioid Pain Patches Distributors List
18.3 Non-opioid Pain Patches Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Non-opioid Pain Patches (2021-2026)
20.2 Global Forecasted Revenue of Non-opioid Pain Patches (2021-2026)
20.3 Global Forecasted Price of Non-opioid Pain Patches (2015-2026)
20.4 Global Forecasted Production of Non-opioid Pain Patches by Region (2021-2026)
20.4.1 North America Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.3 Europe Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.7 Africa Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.9 South America Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Non-opioid Pain Patches Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Non-opioid Pain Patches by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Non-opioid Pain Patches by Country
21.2 East Asia Market Forecasted Consumption of Non-opioid Pain Patches by Country
21.3 Europe Market Forecasted Consumption of Non-opioid Pain Patches by Countriy
21.4 South Asia Forecasted Consumption of Non-opioid Pain Patches by Country
21.5 Southeast Asia Forecasted Consumption of Non-opioid Pain Patches by Country
21.6 Middle East Forecasted Consumption of Non-opioid Pain Patches by Country
21.7 Africa Forecasted Consumption of Non-opioid Pain Patches by Country
21.8 Oceania Forecasted Consumption of Non-opioid Pain Patches by Country
21.9 South America Forecasted Consumption of Non-opioid Pain Patches by Country
21.10 Rest of the world Forecasted Consumption of Non-opioid Pain Patches by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer